Join Us March 5th for "Patient Stories Without a Fixed Address"


Hi!

We all know that patient advocacy shows up differently across organizations. Sometimes it sits within medical. Sometimes commercial. Sometimes corporate affairs. Sometimes it stands alone.

Where it sits changes how we tell those stories, and how the patient voice ultimately shows up in our narratives.

Our inaugural Patient Advocacy & Engagement Roundtable panel brings together leaders who have overseen advocacy from multiple vantage points, including within integrated corporate affairs functions and organization-wide patient centricity roles.

Patient Stories Without a Fixed Address

📅 Thursday, March 5th | 12-1 p.m. ET
​Register here​
​(Exclusive to T2B Pro and Student members)

We’ll examine:

  • How organizational design influences comms strategy
  • What strong partnership between advocacy and corporate affairs actually requires
  • Where friction tends to emerge between lived experience and corporate narrative
  • Approaches for responsibly incorporating patient insight into leadership messaging, campaigns, and reputation strategy

This conversation is designed for communicators operating at the enterprise level, those shaping brand, policy, investor, and employee narratives while ensuring patient voices are reflected with care and credibility.

Meet our panelists:

  • Rebecca Cowens-Alvarado, MPH, Director, U.S. Advocacy Relations, Oncology @ Bayer
  • ​Stephanie Kenney, Senior Vice President, Corporate Affairs @ Avidity Biosciences
  • ​Jeff Sears, T2B PA&E Roundtable Member and Global Head, Strategy & Operations, Communications and Investor Relations, Astellas U.S. (panel moderator)
  • ​Dr. Anthony Yanni, Founder & CEO @ Lucid Health Solutions

Thank you to our PA&E Roundtable members for curating a thoughtful first session.

Lynnea

P.S. - Missed a previous roundtable discussion? The T2B Dashboard for Pro and Student members houses session replays and member resources.

T2B Monthly

Read more from T2B Monthly

Hi! A quick reminder that tomorrow we’ll hold our Q2 Patient Advocacy & Engagement Roundtable event. This conversation will look at how biopharma communications are actually experienced by patient organizations... where messaging resonates, where it falls short, and what helps build stronger, more trusted relationships over time. Our speakers will share perspectives on what patient advocacy groups need from biopharma communicators, including how trust is built in practice, what makes...

Hi, Our Q1 masterclass explored what it means for biopharma communicators to show up fully as strategic partners, focusing on how we understand the business, structure our work, and make our impact more visible. Andrea Johnston led the session, bringing a builder’s perspective shaped by 30+ years across corporate, agency, and entrepreneurship (including one of the OG firms in our industry, Pure Communications). Here are 10 takeaways that stood out: Understand the economics of your clients' or...

Hi! Patient organizations are the closest link to the communities biopharma aims to serve. They see firsthand how messaging lands, including where it resonates, where it misses, and where it creates unintended friction. Our upcoming Patient Advocacy & Engagement Roundtable event brings together leaders across patient advocacy, healthcare communications, and patient-centered innovation to share how biopharma communications are experienced on the receiving end. What Patient Advocacy...